Virtual Medicinal Product (VMP)
-
Rivastigmine 4.6mg/24hours transdermal patches
Name Details
Current Name
Rivastigmine 4.6mg/24hours transdermal patches
|
Start Date
22-10-2007
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- patch
- Unit Dose UOM
- patch
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Transdermal
- Form
- Transdermal patch
- Ontology Form/Route
- patch.transdermal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N06DA03
BNF |
Current BNF
04110000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04110000
|
Start Date
08-05-2008
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
12315111000001105 |
22-10-2007 |
|
VMP Ingredients
VMP ingredients table
Rivastigmine |
Based on Ingredient Substance |
|
4.6 mg |
24 hour |
Name
Rivastigmine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
4.6
Strength and UOM (Dmr)
24
Parent Products
-
VTM
Rivastigmine
-
VMP
(Current) Rivastigmine 4.6mg/24hours transderm...
Virtual Medicinal Product Pack (VMPP) Information